Federal Register / Vol. 75, No. 167 / Monday, August 30, 2010 / Notices 52957 

Programs, is not applicable to these 

grant applications. 

IV. Application and Submission 

Information 

1. Address To Request Application 

Package 

Application kits are available by 

writing to the U.S. Department of Health 

and Human Services, Administration on 

Aging, Office for American Indian, 

Alaskan Native, and Native Hawaiian 

Programs, Washington, DC 20001; by 

calling Cecelia Aldridge, telephone: 

(202) 357–3422; or online at http:// 

www.grants.gov, http://www.aoa.gov 

under Grant Opportunities →Funding 

Opportunities, or http:// 

www.olderindians.org. 

2. Application Submission 

Requirements 

An original and complete application 

must include all attachments and be 

signed by the principal official of the 

tribe. 

Applicants are encouraged to submit 

applications electronically via e-mail to 

Grants.Office@aoa.hhs.gov with the 

following in the subject line of the 

e-mail: ‘‘FY2011–2014 Title VI 

Application: (insert your tribal 

organization name).’’ 

If sending via overnight delivery 

service, applications must be submitted 

to the U.S. Department of Health and 

Human Services, Administration on 

Aging, Office of Grants Management, 

One Massachusetts Ave., NW., Room 

4714, Washington, DC 20001, attn: YiHsin Yan. 

Faxed applications will not be 

accepted. 

3. Submission Dates and Times 

To receive consideration, applications 

must be received electronically by 11:59 

p.m. EST on November 30, 2010, or 

postmarked by the overnight delivery 

service no later than November 30, 

2010. If AoA’s 

Grants.Office@AoA.HHS.gov e-mail site 

cannot reasonably be used, a hard copy 

application and all attachments must be 

provided to an overnight delivery 

service and documented with a receipt 

by November 30, 2010. 

V. Screening Criteria 

Each application submitted will be 

screened to determine whether it was 

received by the closing date and time. 

In addition, applications received by the 

closing date and time will be screened 

for completeness and conformity with 

the requirements outlined in Sections III 

and IV of this Notice and the Program 

Announcement. Only completed and 

signed applications that meet these 

requirements will be considered for 

funding. 

VI. Application Review Information 

Not Applicable 

VII. Agency Contacts 

For further information/questions 

regarding your application, contact M. 

Yvonne Jackson, Ph.D., U.S. Department 

of Health and Human Services, 

Administration on Aging, Office for 

American Indian, Alaskan Native, and 

Native Hawaiian Programs, One 

Massachusetts Avenue, NW., Room 

5013, Washington, DC 20001; telephone 

(202) 357–3501; fax (202) 357–3560; 

e-mail Yvonne.Jackson@aoa.hhs.gov. 

Dated: August 24, 2010. 

Kathy Greenlee, 

Assistant Secretary for Aging. 

[FR Doc. 2010–21565 Filed 8–27–10; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Resource for Biopreservation. 

Date: September 14, 2010. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924, 301–435–0725, 

johnsonw@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Cardiovascular Computational Model. 

Date: September 17, 2010. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Youngsuk Oh, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7182, 

Bethesda, MD 20892–7924, 301–435–0277, 

yoh@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: August 24, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21526 Filed 8–27–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0445] 

Supplemental Funding Under the Food 

and Drug Administration’s Food 

Emergency Response Laboratory 

Network Microbiological Cooperative 

Agreement Program (U18) PAR–09– 

215; Request for Supplemental 

Applications 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of intent to provide 

supplemental funding to the existing 

cooperative agreement (U18), PAR–09– 

215, with the Food and Drug 

Administration and a request for 

supplemental applications. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of supplemental grant funds 

for the support of Food Emergency 

Response Laboratory Network (FERN) 

Microbiological Laboratories. The goal 

of these FERN Microbiological 

Laboratories supplements is a minor 

program expansion to enhance the lab 

capabilities to handle human 

pathogenic bacteria in animal feed. 

DATES: Important dates are as follows: 

1. The supplemental application due 

date is August 30, 2010. 

2. The anticipated start date is 

September 2010. 

3. The opening date is August 30, 

2010. 

4. The expiration date is September 6, 

2010. 


jlentini on DSKJ8SOYB1PROD with NOTICES
52958 Federal Register / Vol. 75, No. 167 / Monday, August 30, 2010 / Notices 

FOR FURTHER INFORMATION CONTACT: Tim 

McGrath, Office of Regulatory Affairs, 

Food and Drug Administration, 5600 

Fishers Lane, rm. 12–41, Rockville, MD 

20857, 301–827–1028, email: 

timothy.mcgrath@fda.hhs.gov; or 

Camille R. Peake, Food and Drug 

Administration, 5630 Fishers Lane, rm. 

2105, Rockville, MD 20857, 301–827– 

7168, FAX: 301–827–7101, email: 

Camille.Peake@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description 

For more information on the original 

funding opportunity announcement 

(FOA) for the FERN Microbiological 

Laboratories, please refer to the full 

FOA located at http://grants.nih.gov/ 

grants/guide/pa-files/PAR–09–215.html. 

The program is further described in the 

Catalog of Federal Domestic Assistance 

under 93.103. 

A. Background 

This Federal Register announcement 

issued by FDA under the FERN 

Microbiological Cooperative Agreement 

Program Grant mechanism (U18) is to 

solicit applications from existing FERN 

Microbiology Laboratories to enhance 

current Cooperative Agreement Program 

(CAP) capabilities. The FERN 

cooperative agreements are to enable the 

analyses of foods and food products in 

the event that laboratory surge capacity 

is needed by FERN and FDA for 

analyses related to microbiological 

contamination, either through 

intentional or unintentional means. The 

supplemental grant funds will enable 

analyses of human pathogenic bacteria 

found in animal feed, for samples 

collected by Federal, State, or local 

agencies. Numbers of samples and 

scheduling of samples will be done by 

the FERN National Program Office 

(NPO) in coordination with State/local 

lab authorities. 

These supplemental grant funds will 

also be utilized to enhance animal feed 

analysis results through the usage of 

standardized methods, equipment 

platforms (provided by the grant), 

analytical worksheets, and electronic 

reporting. The supplemental funds will 

also provide training and proficiency 

testing for each method/platform. 

Minimal quality management systems 

will be initiated for each lab, based on 

existing systems in place in each lab 

and consultations between the FERN 

NPO and each lab management group. 

Each laboratory shall develop its own 

consensus decisionmaking, size, and 

format. Federal agency representatives 

may be invited to be nonmember 

liaisons or advisors to the laboratory 

and its meetings. Supplemental funds 

may not be used for Federal employees 

to travel to or participate in these 

meetings. 

B. Research Objectives 

Selected FDA FERN Microbiological 

Cooperative Agreement Laboratories 

(CAP labs) will participate in a special 

Cooperative Agreement program to 

enhance their ability to handle human 

pathogenic bacteria in animal feed. This 

additional program will be compatible 

with other FERN Cooperative 

Agreement work that the selected 

laboratories will be performing. This 

special program will involve screening 

and detection studies for selected 

pathogens (Listeria, Salmonella, 

Escherichia coli O157:H7 and generic E. 

coli). The isolates will be tested using 

methods agreed upon in consultation 

with the Center for Veterinary 

Medicine’s (CVM) Office of Research, 

most of which are already being used to 

isolate these organisms from human 

foods. The selected labs will participate 

in FERN food defense/food safety 

assignments. The participation in this 

cooperative agreement will expand the 

ability of FERN to screen for potential 

foodborne pathogens in these feed 

matrices. In addition, this project will 

provide CVM with information needed 

to assess future testing needs. 

C. Eligibility Information 

These supplemental grant funds are 

only available to existing grant 

recipients from State, local, and tribal 

government FERN laboratories and are 

authorized by section 312 of the Public 

Health Security and Bioterrorism 

Preparedness and Response Act of 2002 

(Public Law 107–188) (42 U.S.C. 247b20). This program is described in the 

Catalog of Federal Assistance under 

number 93.448. All projects developed 

with these funds at State, local, and 

tribal levels must have national 

implication or application that can 

enhance Federal food and feed safety 

and security programs. 

D. Requirements 

Laboratories will be selected based on 

the following criteria: 

• If it’s an existing FDA FERN 

Microbiological Cooperative Agreement 

Laboratory; 

• If it has routine microbiological 

capabilities as demonstrated through 

established, ongoing State testing 

programs, preferably those involving 

animal feed testing; 

• If it participates in FERN Food 

Safety/Food Defense surveillance 

assignments; 

• If it participates in FERN proficiency 

testing; and 

• If it has a geographically balanced 

distribution of the selected laboratories. 

II. Award Information/Funds Available 

A. Award Amount 

FDA anticipates providing 

approximately $50,000 total costs 

(direct costs only) in support of this 

supplemental program in fiscal year 

2010. It is estimated that up to six 

microbiological laboratories will be 

supplemented at the level requested, but 

not exceeding $50,000 total costs (direct 

costs only) for a 1-year minor program 

expansion. 

B. Length of Support 

The initial award will be for a 1-year 

performance period and any additional 

funding related to this supplement will 

be dependant on successful 

performance and fiscal appropriations. 

III. Paper Application and Submission 

Information 

To submit an application in response 

to this supplemental notice, applicants 

should download the PHS–398 form at 

http://grants.nih.gov/grants/funding/ 

phs398/phs398.html. 

Submit the paper application to: 

Camille R. Peake, Food and Drug 

Administration, 5630 Fishers Lane, 

rm. 2105, Rockville, MD 20857, 

301–827–7168; and 

Jenny Gabb, Office of Regulatory 

Affairs (HFC–150), Food and Drug 

Administration, 5600 Fishers Lane, 

rm. 12–07, Rockville, MD 20857, 

301–827–8299. 

Dated: August 24, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–21480 Filed 8–27–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Solicitation for Nominations for 

Members of the U.S. Preventive 

Services Task Force (USPSTF) 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Solicits nominations for new 

members of USPSTF. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) invites 

nominations of individuals qualified to 

serve as members of the U.S. Preventive 

Services Task Force (USPSTF). 


jlentini on DSKJ8SOYB1PROD with NOTICES